Cannabis Legalization in Germany- An Entire Industry Is Waiting

In April 2023, the German government agreed on a draft. This was presented by Federal Health Minister Lauterbach and Federal Agriculture Minister Özdemir. The intention was to avoid possible conflicts with the EU or other countries. Therefore, the original plans were revised.

The result is that the key points are no longer quite so far-reaching. The permitted amount for personal use was initially to be a maximum of 30 grams. It has now been lowered to 25 grams.

Read more about cannabis legalization in Germany and find the most important cannabis news of the day with the Hemp.im mobile app.

Cannabis cultivation and consumption

For private cultivation, the original plan for cannabis legalization remains in place. The key framework points are:

Three female flowering plants per adult person are allowed.
Children and adolescents are not allowed access.
Consumption is prohibited near schools and daycare centers.
There is a ban before 8 p.m. in pedestrian areas.
If minors are caught with cannabis, they must participate in so-called intervention and prevention programs.
Erasure of old convictions
The state also wants to use cannabis legalization to decriminalize the use of the intoxicant. Therefore, there will be the possibility to erase previous convictions from the Federal Central Register due to the new regulations.

This will have a positive effect on job applications. After all, many companies require an extract from the register. In this way, they want to ensure that applicants have a “clean slate.”

Ensuring controlled delivery

Dispensing is initially not allowed in licensed stores after cannabis legalization. Sales will take place in non-profit “cannabis clubs.”

In these “social clubs,” adults between the ages of 18 and 21 will be allowed to obtain a maximum of 25 grams in one purchase. They will be allowed to purchase 30 grams per month. Those who have reached the age of 21 will receive 25 grams per purchase, but a maximum of 50 grams per month.

What the key points presented prohibit, however, is consumption in clubrooms. This regulation is criticized by experts as out of touch with reality.

Cannabis legalization will create a larger market

In the previous market, it was possible to buy medical cannabis, nutritional supplements, and wellness and cosmetic products containing CBD. After cannabis legalization, about four million adult cannabis users will be added. Legal sales will earn the companies involved billions of euros.

The medical cannabis market serves about 80,000 patients

There will be medical use. Here, sales are made primarily through doctors and pharmacies.

The cannabis needed for medical purposes comes from special flowers. They have the prescribed and necessary quality. Extracts or medicines such as dronabinol are then made from them.

The recreational and pleasure market will grow after cannabis legalization

With a vision to succeed in the cannabis industry

So far, there are only a few companies in Germany that focus entirely on the cannabis market. To survive in this market, you have to cover all the individual areas. This means that a cannabis company is best active in all possible “playing fields”.

Some are engaged in the research of cannabis or develop cannabis products. Others grow hemp, and still, others are active in sales and distribution. By working together, the individual companies all succeed in realizing their respective potential. In the end, the whole enterprise is successful.

Cannabis legalization in Germany will drive company values

Looking at the stock market listings of cannabis companies, all are currently struggling with falling share prices. But the cornerstones for cannabis legalization in Germany that have now been announced will set something in motion. They could be a decent motivational boost in the right direction in the long term. As such, they could provide a boost to the stock markets and be (very) interesting for certain investors.

In any case, the cannabis market has enormous potential. And Europe’s leading cannabinoid company is one of the key players in this playing field. Until then, players will have to make do with providing young plants and accessories.

But in view of the enormous demand, there are interesting sales opportunities here as well.

__

(Featured image by Yash Lucid via Pexels)

DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in AGITANO, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.